Article Details
Retrieved on: 2021-06-25 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
By Chris Wack. Vir Biotechnology Inc. said it saw positive new data from its ongoing Phase 2 clinical trials of VIR-2218 and ongoing Phase 1 studies of ...
Article found on: www.marketwatch.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here